This discrepancy just isn't shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, that have identical or bigger potencies than copyright as dopamine reuptake inhibitors. These results have evoked a hypothesis that copyright may perform for a so-referred to as "DAT inverse agonist" or "negative allosteri